| Ident. | Authors (with country if any) | Title |
|---|
| 000063 (2021) |
Jennie H. Best [États-Unis] ; Amanda M. Kong [États-Unis] ; Emma Kaplan-Lewis [États-Unis] ; Otis W. Brawley [États-Unis] ; Rachel Baden [États-Unis] ; James L. Zazzali [États-Unis] ; Karen S. Miller [États-Unis] ; James Loveless [États-Unis] ; Krutika Jariwala-Parikh [États-Unis] ; Shalini V. Mohan [États-Unis] | Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement. |
| 000084 (2021) |
Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis] | The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review. |
| 000110 (2021) |
Consolato M. Sergi [Canada] ; Brian Chiu [Canada] | Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000405 (2021) |
Federico Diotallevi [Italie] ; Anna Campanati [Italie] ; Giulia Radi [Italie] ; Michele M. Luchetti [Italie] ; Devis Benfaremo [Italie] ; Corrado Tagliati [Italie] ; Oriana Simonetti [Italie] ; Annamaria Offidani [Italie] | Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association. |
| 000437 (2021) |
Hozaifa Khalil Elsawah [Égypte] ; Mohamed Ahmed Elsokary [Égypte] ; Mahmoud Gamal Elrazzaz [Égypte] ; Ahmed Hanei Elshafie [Égypte] | Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials. |
| 000506 (2021) |
Barbara Burgos-Blasco [Espagne] ; Noemi Güemes-Villahoz [Espagne] ; Beatriz Vidal-Villegas [Espagne] ; Juan Donate-Lopez [Espagne] ; Julian Garcia-Feijoo [Espagne] | Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir. |
| 000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
| 000620 (2021) |
Alessandro Lucchesi [Italie] ; Paolo Silimbani [Italie] ; Gerardo Musuraca [Italie] ; Claudio Cerchione [Italie] ; Giovanni Martinelli [Italie] ; Paola Di Carlo [Italie] ; Mariasanta Napolitano [Italie] | Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease. |
| 000629 (2021) |
Ant Nio Ferreira [Portugal] ; Ant Nio Oliveira-E-Silva [Portugal] ; Paulo Bettencourt [Portugal] | Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. |
| 000649 (2021) |
Grace Salacup [États-Unis] ; Kevin Bryan Lo [États-Unis] ; Fahad Gul [États-Unis] ; Eric Peterson [États-Unis] ; Robert De Joy [États-Unis] ; Ruchika Bhargav [États-Unis] ; Jerald Pelayo [États-Unis] ; Jeri Albano [États-Unis] ; Zurab Azmaiparashvili [États-Unis] ; Sadia Benzaquen [États-Unis] ; Gabriel Patarroyo-Aponte [États-Unis] ; Janani Rangaswami [États-Unis] | Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: A single tertiary center cohort. |
| 000678 (2021) |
Bin Zhou [Japon] ; Shinsuke Kojima [Japon] ; Atsuhiko Kawamoto [Japon] ; Masanori Fukushima [Japon] | COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. |
| 000773 (2021) |
Dorna Kheirabadi [Iran] ; Fatemeh Haddad [Iran] ; Razieh S. Mousavi-Roknabadi [Iran] ; Mohammad Rezaeisadrabadi [Iran] ; Hamidreza Dehghan [Iran] ; Aylar Fazlzadeh [Iran] | A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. |
| 000988 (2020) |
Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Harish Kumar [Inde] ; Dhruv Mahendru [Inde] ; Pramod Avti [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Nishant Shekhar [Inde] ; Subodh Kumar [Inde] ; Rahul Singh [Inde] ; Ashutosh Singh [Inde] ; Deba Prasad Dhibar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde] | Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. |
| 000A63 (2020) |
John P. Knorr [États-Unis] ; Veronika Colomy [États-Unis] ; Christine M. Mauriello [États-Unis] ; Seung Ha [États-Unis] | Tocilizumab in patients with severe COVID-19: A single-center observational analysis. |
| 001120 (2020) |
Adam Brufsky [États-Unis] | Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. |
| 001150 (2020) |
Huiying Xue [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Pan Luo [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine] | Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China. |
| 001327 (2020) |
Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine] ; Junfen Fu [République populaire de Chine] ; Shiqiang Shang [République populaire de Chine] ; Qiang Shu [République populaire de Chine] ; Ting Zhang [République populaire de Chine] | Epidemiological analysis of COVID-19 and practical experience from China. |
| 001409 (2020) |
Jaya Prasad Tripathy [Inde] | Does pandemic justify the use of hydroxychloroquine for treatment and prevention of COVID-19 in India? |
| 001519 (2020) |
Vui Heng Chong [Brunei] ; Pui Lin Chong [Brunei] ; Dhiya Metussin [Brunei] ; Rosmonaliza Asli [Brunei] ; Riamiza Natalie Momin [Brunei] ; Babu Ivan Mani [Brunei] ; Muhammad Syafiq Abdullah [Brunei] | Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19. |
